Pharmaceuticals: cost containment, pricing, reimbursement (English)

In virtually every country in the world, governments, social security fund managers and health insurers are struggling with ever increasing drug bills. This note explains cost drivers, provides insights into private sector strategies and discusses how to strike the balance between cost containment and access to innovative medicines. Policy makers in many countries are struggling to cope with increasing costs for pharmaceuticals. Pharmaceutical expenses...

DETAILS

Author

Lakshminarayanan, Rama [editor];

Seiter,Andreas;
Document Date
2005/08/01
Document Type
Brief
Report Number
35560
Volume No
1
Total Volume(s)
1
Country
World,
Region
Other,
Disclosure Date
2006/03/27
Disclosure Status
Disclosed
Doc Name
Pharmaceuticals: cost containment, pricing, reimbursement
Keywords
research and development need

DOWNLOADS

COMPLETE REPORT

Official version of document (may contain signatures, etc)

Official PDF
TXT*
Total Downloads** : 539
Download Stats
*The text version is uncorrected OCR text and is included solely to benefit users with slow connectivity.

Citation

Lakshminarayanan, Rama [editor]; Seiter,Andreas.

Pharmaceuticals: cost containment, pricing, reimbursement (English). HNP brief ; no. 7 Washington, DC: World Bank. http://documents.worldbank.org/curated/en/884031468137999391

Pharmaceuticals: cost containment, pricing, reimbursement (English)

DETAILS

DOWNLOADS

COMPLETE REPORT

Citation

RELATED LINKS

SUBSCRIBE TO EMAIL ALERTS